NCT06706570 2026-03-24
PIK3CA Mutational Status Assessment
European Institute of Oncology
Recruiting
Clinical Trials
4 trialsNCT06750484 2026-02-27
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
Yale University
Phase 2 Recruiting
NCT06616987 2025-08-28
Prevention of Sacituzumab Govitecan-related Neutropenia in Patients With Metastatic Triple Negative Breast Cancer
Samsung Medical Center
Phase 2 Recruiting
NCT06966141 2025-05-11
A Real World Study of Sacituzumab Govitecan
Fudan University
Recruiting